Skip to main content
Caplight Logo









Corami Biotech Inc.

Corami Biotech Inc.

Private
Memphis, TennesseeHealthcare & Life Scienceshttps://www.coramibio.com/

Last Round

Seed Round

Apr 22, 2026

Total Funding Raised

$1.76M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Corami Biotech Inc. is a healthcare technology company developing a platform for targeted cardiac therapeutic delivery and placement to treat heart disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

cardiac drug deliverydrug delivery platformepicardial deliverytherapeutic hydrogelminimally invasive devicecombination productlocal drug deliverycardiac gene therapyatrial fibrillationbiomaterialsclinical-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Corami Biotech Inc. Comparables

Compare Corami Biotech Inc. with similar companies based on industry and business-model similarity.

Corami Biotech Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SmartCella Holding AB
73%
BioCardia Inc
68%
AtriCure Inc
59%

Corami Biotech Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundApr 22, 2026
GrantDec 9, 2025
AcceleratorDec 12, 2024
AngelOct 24, 2024
GrantSep 1, 2024
Grant
Sep 23, 2019

Corami Biotech Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    $230K raised in Seed Round.

  • Dec 9, 2025

    Received grant funding to support operations.

Corami Biotech Inc. Filings

Explore SEC and related filing metadata, where available.

Corami Biotech Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Corami Biotech Inc.'s valuation, stock price, and market status.

Is Corami Biotech Inc. a public or private company?

Corami Biotech Inc. is a private company.

What is the current stock price of Corami Biotech Inc.?

Corami Biotech Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Corami Biotech Inc. worth (valuation)?

Valuation information for Corami Biotech Inc. is not publicly available.

Can I buy Corami Biotech Inc. stock?

Corami Biotech Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Corami Biotech Inc.'s last funding round?

Corami Biotech Inc.'s most recent funding round was Seed Round on April 22, 2026.

Who are the main investors in Corami Biotech Inc.?

Key investors in Corami Biotech Inc. include Tennessee Technology Development Corporation, National Heart, Lung, and Blood Institute.

Will Corami Biotech Inc. IPO soon?

No public IPO plans have been announced for Corami Biotech Inc..

How can I track Corami Biotech Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Corami Biotech Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMemphis, Tennessee
Year Founded2024
Last FundingApr 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?